Rockingstone Advisors LLC Johnson & Johnson Transaction History

Rockingstone Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jul 09, 2024	SELL	$145.6 - $158.88 $196,414 - $214,329	-1,349 Closed	0 $0
Q3 2023 Jul 09, 2024	SELL	$155.75 - $174.48 $31,461 - $35,244	-202 Reduced 13.02%	1,349 $210 Million
Q2 2023 Jul 09, 2024	SELL	$154.35 - $166.11 $6,482 - $6,976	-42 Reduced 2.64%	1,551 $257 Million
Q1 2023 Jul 09, 2024	SELL	$151.05 - $180.26 $8,609 - $10,274	-57 Reduced 3.45%	1,593 $247 Million
Q4 2022 Jul 09, 2024	BUY	$160.2 - $179.79 $264,330 - $296,653	1,650 New	1,650 $291 Million

4,219

1.7B

12.5M

10.3M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $419B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Rockingstone Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Rockingstone Advisors LLC with notifications on news.